Treating Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck Unsuitable to Receive Cisplatin-Based Therapy

Concurrent chemoradiotherapy with high-dose cisplatin (100 mg/m(2) every 3 weeks) is the preferred regimen with curative intent for patients with unresected locally advanced squamous cell carcinoma of the head and neck (LA SCCHN). This treatment is associated with acute and late toxicities, includin...

Descripción completa

Detalles Bibliográficos
Autores principales: Porceddu, Sandro V., Scotté, Florian, Aapro, Matti, Salmio, Satu, Castro, Ana, Launay-Vacher, Vincent, Licitra, Lisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6987395/
https://www.ncbi.nlm.nih.gov/pubmed/32039012
http://dx.doi.org/10.3389/fonc.2019.01522

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6987395/
https://www.ncbi.nlm.nih.gov/pubmed/32039012
http://dx.doi.org/10.3389/fonc.2019.01522

Ejemplares similares